by TractManager | Jun 1, 2021 | Emerging Technology Report
Lumakras (sotorasib) is an oral KRAS G12C inhibitor designed to block the abnormal proliferative action of mutant KRAS protein. It is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer...
by TractManager | May 28, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on the use of botulinum toxin (BTX) for treatment of pain associated with temporomandibular disorders.Technology Description: BTX, a neurotoxin produced by the bacterium Clostridium (C.) botulinum, is classified into 8 distinct...
by TractManager | May 27, 2021 | Molecular Test Assessment
This report evaluates the AlloSure Kidney test for acute and chronic kidney transplant rejection (antibody-mediated and/or T-cell mediated) in patients for either surveillance or for-cause evaluation.If you have a Hayes login, click here to view the full report on the...
by TractManager | May 18, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on acupuncture (AP) for treatment of allergic rhinitis.Technology Description: Traditional AP employs thin metal needles to pierce the skin at specific, defined sites. Related treatments involve application of pressure,...
by TractManager | May 13, 2021 | Molecular Test Assessment
This report evaluates the analytical validity, clinical validity, and clinical utility of the Nodify XL2 test.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments